These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Involvement of phosphatidylinositol 3 kinase in the progesterone-induced oocyte maturation in Rana dybowskii. Ju JW; Bandyopadhyay A; Im WB; Chung J; Kwon HB; Choi HS Gen Comp Endocrinol; 2002 Apr; 126(2):213-20. PubMed ID: 12030777 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of autophagic proteolysis by inhibitors of phosphoinositide 3-kinase can interfere with the regulation of glycogen synthesis in isolated hepatocytes. Dubbelhuis PF; Van Sluijters DA; Blommaart EF; Gustafson LA; Van Woerkom GM; Herling AW; Burger HJ; Meijer AJ Biochem J; 2002 Dec; 368(Pt 3):827-33. PubMed ID: 12371905 [TBL] [Abstract][Full Text] [Related]
46. Phosphatidylinositol 3-kinase and Ras/mitogen-activated protein kinase signaling pathways are required for the regulation of 5-aminolevulinate synthase gene expression by insulin. Scassa ME; Guberman AS; Varone CL; Cánepa ET Exp Cell Res; 2001 Dec; 271(2):201-13. PubMed ID: 11716532 [TBL] [Abstract][Full Text] [Related]
47. Glut-1 translocation in FRTL-5 thyroid cells: role of phosphatidylinositol 3-kinase and N-glycosylation. Samih N; Hovsepian S; Aouani A; Lombardo D; Fayet G Endocrinology; 2000 Nov; 141(11):4146-55. PubMed ID: 11089547 [TBL] [Abstract][Full Text] [Related]
48. The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains. Dittmann A; Werner T; Chung CW; Savitski MM; Fälth Savitski M; Grandi P; Hopf C; Lindon M; Neubauer G; Prinjha RK; Bantscheff M; Drewes G ACS Chem Biol; 2014 Feb; 9(2):495-502. PubMed ID: 24533473 [TBL] [Abstract][Full Text] [Related]
49. Phosphoinositide 3-kinase inhibits megalin-mediated transcytosis of thyroglobulin across thyroid epithelial cells at a post-sorting level. Marinò M; Chiovato L; Lisi S; Pinchera A; McCluskey RT Eur J Endocrinol; 2001 Oct; 145(4):477-83. PubMed ID: 11581008 [TBL] [Abstract][Full Text] [Related]
50. [The involvement of phosphoinositide 3-kinase (PI3-Kinase) and phospholipase C gamma (PLC gamma) pathway in the morphine-induced supraspinal antinociception in the mouse]. Narita M; Ohnishi O; Nemoto M; Aoki T; Suzuki T Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb; 21(1):7-14. PubMed ID: 11400324 [TBL] [Abstract][Full Text] [Related]
51. Pharmacological inhibition of phosphoinositide 3 and TOR kinases improves survival of Drosophila melanogaster. Moskalev AA; Shaposhnikov MV Rejuvenation Res; 2010; 13(2-3):246-7. PubMed ID: 20017609 [TBL] [Abstract][Full Text] [Related]
53. Structural insight into substrate specificity and regulatory mechanisms of phosphoinositide 3-kinases. Djordjevic S; Driscoll PC Trends Biochem Sci; 2002 Aug; 27(8):426-32. PubMed ID: 12151228 [TBL] [Abstract][Full Text] [Related]
54. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Knight ZA; Gonzalez B; Feldman ME; Zunder ER; Goldenberg DD; Williams O; Loewith R; Stokoe D; Balla A; Toth B; Balla T; Weiss WA; Williams RL; Shokat KM Cell; 2006 May; 125(4):733-47. PubMed ID: 16647110 [TBL] [Abstract][Full Text] [Related]
55. The role of class I phosphoinositide 3-kinase in T-cell function and autoimmunity. Fruman DA Biochem Soc Trans; 2007 Apr; 35(Pt 2):177-80. PubMed ID: 17371231 [TBL] [Abstract][Full Text] [Related]
56. A robust screen for inhibitors and enhancers of phosphoinositide-3 kinase (PI3K) activities by ratiometric fluorescence superquenching. Stankewicz C; Rininsland FH J Biomol Screen; 2006 Jun; 11(4):413-22. PubMed ID: 16490774 [TBL] [Abstract][Full Text] [Related]
57. Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment. Stein RC Endocr Relat Cancer; 2001 Sep; 8(3):237-48. PubMed ID: 11566615 [TBL] [Abstract][Full Text] [Related]
58. Selective role of PI3K delta in neutrophil inflammatory responses. Sadhu C; Dick K; Tino WT; Staunton DE Biochem Biophys Res Commun; 2003 Sep; 308(4):764-9. PubMed ID: 12927784 [TBL] [Abstract][Full Text] [Related]
59. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Vlahos CJ; Matter WF; Hui KY; Brown RF J Biol Chem; 1994 Feb; 269(7):5241-8. PubMed ID: 8106507 [TBL] [Abstract][Full Text] [Related]